Biosketch Marta Crespo

Marta Crespo
Current position

Senior Investigator and Translational Research Coordinator at VHIO’s Experimental Hematology Group

Past Positions
  • 2001-2007 PhD Student in Experimental Hematology lab, Hospital Clínic, Barcelona
  • 2007-2010 Post-doctoral Research Scientist, Institute for Cancer Genetics, Columbia University, NYC
  • 2010-2016 Tenure-track research scientist, Experimental Hematology lab, Vall d’Hebron Institut de Recerca, Barcelona
Academic Qualifications
  • 2013- Ramon y Cajal investigator
  • 2006-PhD by Universitat de Barcelona-Biopathology in Medicine
  • 2001-Degree in Biology by the Universitat de Barcelona
Areas of Research
  • Mechanisms of progression and pathogenesis in lymphoid malignancies
  • Pre-clinical study of therapeutic options in models that mimic the tumoral immune microenvironment (focus on CNS)
  • Biomarkers for rational and precise treatment of patients
Prizes and Scholarships
  • Ramon y Cajal tenure-track fellowship (2013)
  • MEC-Fulbright Postdoctoral Fellowship (2007)
  • American Society of Hematology Abstract Achievement Award (2016)
  • Extraordinary Thesis Award (2007)
  • AECC-2018 Macrophage mediated immunotherapy optimization in lymphomas affecting the central nervous system.
  • ISCIII-2018 Role of immune surveillance and evasion in the physiopathology and immunotherapy in central nervous system lymphomas.
  • AECC-2016- Targeted therapy for acute myeloid leukemia: ex vivo testing under conditions mimicking the bone marrow microenvironment.
  • ISCIII-2014- New therapeutic options for primary central nervous system lymphoma: targeting deregulated signaling pathways using in vivo models.
Most relevant scientific publications
  • Isabel Jiménez; Júlia Carabia; Sabela Bobillo; Carles Palacio; Pau Abrisqueta; Carlota Pagès; Juan C. Nieto; Josep Castellví; Francisco Martínez-Ricarte; Lourdes Escoda; Cristóbal Perla; Dennis H. Céspedes Torrez; Joan Boix; Noelia Purroy; Lluís Puigdefàbregas; Joan Seoane; Francesc Bosch; Marta Crespo. Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.Journal of Neuro-Oncology. 20/07/2020.
  • Marta Crespo; Sabela Bobillo; Laura Escudero; Regina Mayor; Priyanka Raheja; Cecilia del Carmen Carpio; Carlota Rubio-Pérez; Bárbara Tazón-Vega; Carles Palacio; Júlia Carabia; Isabel Jiménez; Juana C. Nieto; Júlia Montoro; Francisco Martínez-Ricarte; Josep Castellví; Marc Simó; Lluís Puigdefàbregas; Pau Abrisqueta; Joan Seoane; Francesc Bosch. Cell Free Circulating Tumor DNA in Cerebrospinal Fluid detects and monitors Central Nervous System Involvement of B-Cell Lymphomas. Haematologica. 20/02/2020.
  • Júlia Carabia; Cecilia Carpio; Pau Abrisqueta; Isabel Jiménez; Noelia Purroy; Eva Calpe; Carles Palacio; Francesc Bosch; Marta Crespo. Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Scientific Reports. 25/09/2017.
  • Noelia Purroy; Pau Abrisqueta; Júlia Carabia; Cecilia Carpio; Eva Calpe; Carles Palacio; Josep Castellví; Francesc Bosch; Marta Crespo. Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.Leukemia. pp. 1993 – 2004. 01/10/2014.
  • E Calpe; C Codony; MJ Baptista; P Abrisqueta; C Carpio; N Purroy; F Bosch; M Crespo. ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation. 118 – 16, pp. 4401 – 4410. 2011.
  • Marta Crespo; Neus Villamor; Eva Giné; Ana Muntañola; Dolors Colomer; Teresa Marafioti; Margaret Jones; Mireia Camós; Elias Campo; Emili Montserrat; Francesc Bosch. ZAP-70 expression in normal pro/pre B-cells, mature B-cells, and in B-cell acute lymphoblastic leukaemia. Clinical Cancer Research. 12 – 3, pp. 726 – 734. 2006.
  • Marta Crespo; Francesc Bosch; Neus Villamor; Beatriz Bellosillo; Dolors Colomer; Maruja Rozman; Armando López-Guillermo; Elias Campo; Emili Montserrat. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine. 348- 18, pp. 1764 – 1775. 2003.
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.